ロード中...

EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3

Programmed cell death (PD)-1/PD-1 ligand-1 (PD-L1)-targeted therapy has emerged as a promising therapeutic strategy for lung cancer. However, whether EML4-ALK regulates PD-L1 expression in lung cancer remains unknown. A total of 532 pulmonary adenocarcinomas (pADCs), including 58 ALK-translocated tu...

詳細記述

保存先:
書誌詳細
出版年:Oncoimmunology
主要な著者: Koh, Jaemoon, Jang, Ji-Young, Keam, Bhumsuk, Kim, Sehui, Kim, Moon-Young, Go, Heounjeong, Kim, Tae Min, Kim, Dong-Wan, Kim, Chul-Woo, Jeon, Yoon Kyung, Chung, Doo Hyun
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4839370/
https://ncbi.nlm.nih.gov/pubmed/27141364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1108514
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!